highlights on datopotamab deruxtecan in advanced nsclc: the tropion-lung01 study
Published 9 months ago • 2.2K plays • Length 3:09Download video MP4
Download video MP3
Similar videos
-
1:37
tropion-lung01 & tropion-lung05: datopotamab deruxtecan for nsclc
-
1:16
ongoing studies for datopotamab deruxtecan in nsclc
-
0:48
tropion-pantumor03: datopotamab deruxtecan in advanced solid tumors
-
18:24
esmo 2023 lung cancer highlights – keynote 671 | alina | tropionlung01 | oncology brothers
-
2:51
highlights on adjuvant alectinib in early alk positive nsclc: the alina study
-
5:18
expert video report on amivantamab in combination therapy for 1l treatment in egfrm, advanced nsclc
-
3:58
highlights on selpercatinib in ret fusion-positive nsclc: the libretto-431 study
-
3:22
begonia: datopotamab deruxtecan and durvalumab in metastatic triple-negative breast cancer
-
1:24
begonia: durvalumab dato-dxd in advanced tnbc
-
1:00
esmo 2023 highlights: advances in egfr lung cancer second-line therapy
-
4:09
highlights on sotorasib plus panitumumab in kras g12c-mutated mcrc: the codebreak 300 study
-
1:37
dr. shuch on caveats of avelumab/axitinib combination in rcc
-
0:46
fda approves capmatinib for advanced lung cancer
-
0:56
dr. apolo on immunotherapy combinations with cabozantinib in genitourinary tumors
-
1:07
double oncogenic hits of 17p13(del) and 1q21(amp) in myeloma
-
1:39
phase i/ii trial of adct-602 in b-all
-
2:21
lung highlights from esmo 2018
-
6:38
pacific trial of durvalumab for lung cancer